Geode Capital Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
VCM
Geode Capital Management's RXST Position: Q1 2026 in Review
Geode Capital Management increased its RxSight (RXST) stake by 9.8% in Q1 2026, buying an estimated $682K and bringing the position to 919,893 shares worth $5.67M. The position accounts for ﹤0.01% of the portfolio, ranked #2674.
Geode Capital Management first reported a position in RXST in Q3 2021 and has held it in 19 quarters since. The position peaked at $41.8M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.
- Geode Capital Management held 919,893 shares of RxSight worth $5.67M as of Q1 2026.
- Geode Capital Management bought 82,094 RxSight shares in Q1 2026, an estimated $682K.
- RxSight made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2674 holding.
- Geode Capital Management first reported a position in RxSight in Q3 2021 and has held it in 19 quarters since.
- Geode Capital Management's RxSight position peaked at $41.8M in Q2 2024.
- 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.
Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.